Palm Research Center is currently enrolling participants in a device clinical trial studying painful neuropathy. Participating in a clinical trial helps to drive scientific progress that will deliver new treatments and therapies to make day-to-day life with T1D easier, safer and healthier. It is part of the JDRF mission of curing, preventing, and treating T1D and its complications.

Qualified participants may receive study related medical exams, laboratory tests, investigational medication, and compensation for time and travel for participation in a study.

The current neuropathy study will be investigating the use of PROVANT device technology. It is a six month study.

Enrollment criteria include:

• Type 1 or Type 2 diabetes with painful neuropathy
• Age 22-79
• A1c <10%

For questions about how to enroll in this opportunity or for more information on JDRF sponsored TrialNet research (testing family members at risk for T1D), contact Palm Research Center at 702-826-2795.